NEUPHORIA THERAPEUTICS INC

Historical 13F Holders

Symbol
NEUP
CUSIP
64136E102
All holders as of
Q2 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 64136E102 since 12/18/2024, newest first.

Filer % of Class Filed
AdvisorShares Trust 13G 5.8% 10/5/2026
Event 9/30/2026
Coastlands Capital LP 13G/A Amendment 1
4.2% 7/28/2026
Event 7/23/2026
Baselake Partners, LP 13G/A Amendment 1
4.1% 2/6/2026
Event 12/31/2025
Lynx1 Capital Management LP 13D/A Amendment 5
16.3% 12/29/2025
Event 12/26/2025
Lynx1 Capital Management LP 13D/A Amendment 4
16.3% 12/2/2025
Event 12/2/2025
Lynx1 Capital Management LP 13D/A Amendment 3
16.3% 11/28/2025
Event 11/28/2025
Lynx1 Capital Management LP 13D/A Amendment 2
16.3% 11/18/2025
Event 11/18/2025
Lynx1 Capital Management LP 13D/A Amendment 1
26.5% 11/10/2025
Event 11/9/2025
Coastlands Capital LP 13G
5.1% 11/5/2025
Event 11/5/2025
Baselake Partners, LP 13G
9.4% 10/31/2025
Event 10/27/2025
Shay Capital LLC 13G
7.3% 10/31/2025
Event 10/24/2025
Lynx1 Capital Management LP 13D
37.1% 10/23/2025
Event 10/21/2025
Armistice Capital, LLC 13G/A Amendment 1
4.99% 2/14/2025
Event 12/31/2024
Apeiron Investment Group Ltd. 13D/A Amendment 2
4.5% 1/28/2025
Event 1/24/2025

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q2 22 1.99 M $8.71 M
2026 Q1 19 1.76 M $7.15 M
2025 Q4 21 1.47 M $5.69 M
2025 Q3 15 195 k $2.30 M
2025 Q2 10 178 k $1.26 M
2025 Q1 8 163 k $935 k
2024 Q4 9 79.7 k $273 k